InvestorsHub Logo
Followers 402
Posts 25660
Boards Moderated 0
Alias Born 10/28/2017

Re: None

Tuesday, 03/06/2018 5:51:12 PM

Tuesday, March 06, 2018 5:51:12 PM

Post# of 7901
IMO: today's ER supports today's price, so from a narrow-minded or daytrader perspective, 100% correct about sedate ER numbers and about what we expected. the company manages to carry a high valuation multiple very well, even at the present price it is over 300m.

The real gold is what is developing this year both in and outside US, which is what most are here for and was important to find out on the CC. Progress on both fronts is far better than expected. Massively greater rev potential in asia vs US, TRXC could become the "captive monopoly" surgical robotic product overseas.

And on a concurrent path in the US, they will obtain added 501k's for more instruments and procedures, and will continue efforts that leas to ongoing sales.

Pope is smart in establishing multiple paths to large sales revenue.

Buy companies with cashflow, execution & undervalued mkt cap. Don't base knowledge on what someone said on a message board. Don't use stop losses- EVER. Lock your shares by placing GTC sell at high price, MMs & shorts cannot borrow them to affect price.